Navigation Links
Biostar Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
Date:8/14/2009

XIANYANG, China, Aug. 14 /PRNewswire-Asia-FirstCall/ -- Biostar Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) ("Biostar" or "the Company"), a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today announced fiscal results for its second quarter ended June 30, 2009.

    SUMMARY FINANCIALS


    Second Quarter 2009 Results

                             Q2 2009        Q2 2008          CHANGE
    Net Sales             $13.2 million  $9.4 million        +40.6%
    Gross Profit           $9.7 million  $5.4 million        +80.5%
    Net Income             $3.9 million  $1.8 million       +119.3%
    EPS (Fully Diluted)           $0.16         $0.08         +100%



    Six Month 2009 Results

                             1H 2009        1H 2008          CHANGE
    Net Sales             $20.7 million  $16.2 million       +27.5%
    Gross Profit          $14.5 million   $9.6 million       +51.9%
    Net Income             $5.7 million   $3.6 million       +58.8%
    EPS (Fully Diluted)           $0.24          $0.15         +60%

Second Quarter 2009 Financial Results

Revenue for the second quarter of 2009 increased 40.6% to approximately $13.2 million compared to approximately $9.4 million for the second quarter of 2008. The increase in revenues resulted from Biostar's enhanced marketing and sales efforts which increased sales of its Xin Aoxing Oleanolic Acid Capsule ("Xin Aoxing Capsule") and Tianqi Dysmenorrhea Capsules ("Tainqi Capsule"). Xin Aoxing Capsule, one of Biostar's flagship OTC products which treats symptoms common to hepatitis B patients, contributed approximately 67.5% to total revenues for the quarter, and increased $4.1 million, or 84.1% to $8.9 million, compared to the second quarter of 2008. The increase was primarily due to market penetration in two additional pro
'/>"/>

SOURCE Biostar Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Friday, August 14, 2009 at 10:30 a.m. EDT
2. Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program
3. Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009
4. Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008
5. Inverness Medical Innovations to Close Cholestech, HemoSense and BioStar Facilities
6. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
7. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
8. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2009 Financial Results on Thursday, August 6, 2009 at 8:30am EDT
9. Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States
10. Lotus Pharmaceuticals, Inc. Announces Patent Pending Gliclazide-Controlled Release Tablets
11. Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Del. and CHARLOTTESVILLE, Va., Dec. 15 /PRNewswire-FirstCall/ ... and the University of Virginia (UVa) in ... into a strategic research collaboration to enhance ... artery disease (CAD) with a secondary focus ... http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO ) ,, The collaborative ...
(Date:12/15/2009)... Dec. 15 On January 20th, 2010, ... for Medical Publication Professionals (ISMPP) will be held ... UK. More than 100 attendees are expected at ... publication professionals, editors, publishers, medical writers and medical ... publications and the impact of guidelines and regulations ...
(Date:12/14/2009)... 14 Vermillion, Inc. (Pink Sheets: ... William C. Wallen, Ph.D. Chief Scientific Officer, ... IDEXX Laboratories, will be joining its board ... plan. ,, "Bill brings more than ... diagnostics and biotechnology," said Gail Page, Vermillion ...
(Date:12/14/2009)... Lionbridge (Nasdaq: LIOX ) ... new, three-year master services agreement with a ... services that serve patients in approximately 100 ... the sole provider for translation of the ... training, human resources, legal, and corporate communications ...
Breaking Biology Technology:AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 2Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 3
... Chromos Molecular,Systems Inc. ("Chromos" or the "Company") ... plan of arrangement (the "Arrangement") involving,among others, ... of Chromos, and Modatech Systems Inc. under ... Columbia) have entered into an agreement,to extend ...
... Sept. 23 Pressure,BioSciences, Inc. (Nasdaq: ... announced,that the Company,s pressure cycling technology ("PCT") ... the Fifth International Conference on,High Pressure Bioscience ... in San Diego, CA. The HPBB Conference ...
... the pioneer,in scalable, high performance cell loading systems, ... of the MaxCyte STX Scalable,Transfection System on Thursday, ... Assays & Cellular Targets Conference in San Diego, ... President of Research and,Development at MaxCyte, "The MaxCyte ...
Other Biology Technology:Chromos announces timing of closing of Arrangement 2Pressure Cycling Technology (PCT) Highlighted in Five Podium Presentations at the Fifth International Conference on High Pressure; PBI Introduces the Patent-pending 'PCT Shredder' at the Meeting 2Pressure Cycling Technology (PCT) Highlighted in Five Podium Presentations at the Fifth International Conference on High Pressure; PBI Introduces the Patent-pending 'PCT Shredder' at the Meeting 3Pressure Cycling Technology (PCT) Highlighted in Five Podium Presentations at the Fifth International Conference on High Pressure; PBI Introduces the Patent-pending 'PCT Shredder' at the Meeting 4MaxCyte Debuts the STX Scalable Transfection System at the A/C/T Assays & Cellular Targets Meeting 2
(Date:12/14/2009)... support of the United Nations Framework Convention on ... Environment Agency hosted the ,Bend the Trend, event ... networking platform and premiere the screening of the ... Atlas of Europe, a joint project of the ... (UNEP) and ESA, is a series of short ...
(Date:12/14/2009)... DURHAM, N.C. As good as laparoscopy is in preventing ... it does have drawbacks, including reduced blood flow and organ ... done through small incisions. , By ... the surgical area during laparoscopy, researchers at Duke University Medical ... during noninvasive surgery. , The gas ethyl nitrite (ENO) ...
(Date:12/13/2009)... a question about how a popular class of ... that reveal previously hidden components of chemical communication ... hallucinations characterize the illness, people with schizophrenia also ... a particular order, difficulties that interfere with their ... said Lee Schroeder, a student in the medical ...
Breaking Biology News(10 mins):'Environmental Atlas of Europe' unveiled at COP15 2Gas improves blood flow and organ status during minimally invasive surgery 2New biosensors reveal workings of anti-psychotic drugs in the living brain 2Oberthur Technologies and Groupe Sephira Team up to Deliver a Secured Electronic Billing Solution 60667 1Oberthur Technologies and Groupe Sephira Team up to Deliver a Secured Electronic Billing Solution 60667 2New Program Developed in the Fight Against Feline Aids 14713 1New Program Developed in the Fight Against Feline Aids 14713 2SleepApneaUSA net Announced An Alternative Sleep Apnea Solution For Commercial Pilots After NTSB Recommended Mandatory Sleep Apnea Certification For T 60662 1SleepApneaUSA net Announced An Alternative Sleep Apnea Solution For Commercial Pilots After NTSB Recommended Mandatory Sleep Apnea Certification For T 60662 2SleepApneaUSA net Announced An Alternative Sleep Apnea Solution For Commercial Pilots After NTSB Recommended Mandatory Sleep Apnea Certification For T 60662 3SleepApneaUSA net Announced An Alternative Sleep Apnea Solution For Commercial Pilots After NTSB Recommended Mandatory Sleep Apnea Certification For T 60662 4SleepApneaUSA net Announced An Alternative Sleep Apnea Solution For Commercial Pilots After NTSB Recommended Mandatory Sleep Apnea Certification For T 60662 5
... to the polls to elect their next president, a new ... , a Cell Press publication, reveals how one species of ... a consensus to go for the more attractive of two ... to follow larger over smaller leaders," said Ashley Ward of ...
... Researchers from the University of North Carolina at ... $10 million to study the many ways cocaine use ... their infants. , The project,s researchers hope their findings ... helping both mothers and children, and prove valuable to ...
... Researchers at MIT,s Center for Energy and Environmental Policy ... of proposed "cap-and-trade" programs that are under consideration in ... gas emissions. The first contribution of the three-part study ... Union,s system and of similar U.S. programs for other ...
Other Biology News:Fish choose their leaders by consensus 2Fish choose their leaders by consensus 3UNC, Yale partner to study effects of cocaine use on mother-infant relationships 2MIT analysis shows how cap-and-trade plans can cut greenhouse emissions 2
Mixing speed from 750-3200RPM, small vortexing orbit of1.0mm...
This Universal 24" X 18" (61 X 45.7cm.) shaker platforms will accept any Thermo Forma shaker flask clip....
Spaced cover glasses to promote effective hybridization...
Antibodies were affinity purified using epitopes specific to RFC1 immobilized on solid support....
Biology Products: